NO20020029L - Fremgangsmåte for fremstilling av amlodipinbenzensulfonat - Google Patents

Fremgangsmåte for fremstilling av amlodipinbenzensulfonat

Info

Publication number
NO20020029L
NO20020029L NO20020029A NO20020029A NO20020029L NO 20020029 L NO20020029 L NO 20020029L NO 20020029 A NO20020029 A NO 20020029A NO 20020029 A NO20020029 A NO 20020029A NO 20020029 L NO20020029 L NO 20020029L
Authority
NO
Norway
Prior art keywords
preparation
methyl
amlodipine benzenesulfonate
formula
amalodipine
Prior art date
Application number
NO20020029A
Other languages
English (en)
Other versions
NO321714B1 (no
NO20020029D0 (no
Inventor
Janos Fischer
Katalin Szoke
Laszlo Dobay
Sandor Levai
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20020029D0 publication Critical patent/NO20020029D0/no
Publication of NO20020029L publication Critical patent/NO20020029L/no
Publication of NO321714B1 publication Critical patent/NO321714B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO20020029A 1999-07-05 2002-01-04 Fremgangsmate for fremstilling av amlodipinbenzensulfonat og farmasoytisk preparat omfattende dette, ftalamidinsyrederivat, forbindelse samt fremgangsmate for fremstilling av nye ftalamidinsyrederivater. NO321714B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1999/000050 WO2001002360A1 (en) 1999-07-05 1999-07-05 Process for preparing amlodipine benzenesulphonate

Publications (3)

Publication Number Publication Date
NO20020029D0 NO20020029D0 (no) 2002-01-04
NO20020029L true NO20020029L (no) 2002-03-05
NO321714B1 NO321714B1 (no) 2006-06-26

Family

ID=10991279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020029A NO321714B1 (no) 1999-07-05 2002-01-04 Fremgangsmate for fremstilling av amlodipinbenzensulfonat og farmasoytisk preparat omfattende dette, ftalamidinsyrederivat, forbindelse samt fremgangsmate for fremstilling av nye ftalamidinsyrederivater.

Country Status (24)

Country Link
US (1) US6596874B1 (no)
EP (1) EP1196383B1 (no)
JP (1) JP3764386B2 (no)
KR (1) KR100585442B1 (no)
CN (1) CN1141297C (no)
AT (1) ATE283841T1 (no)
AU (1) AU777565B2 (no)
BG (1) BG65657B1 (no)
CA (1) CA2376540C (no)
CZ (1) CZ300509B6 (no)
DE (1) DE69922417T2 (no)
DK (1) DK1196383T3 (no)
EA (1) EA004208B1 (no)
EE (1) EE05398B1 (no)
ES (1) ES2234272T3 (no)
HK (1) HK1044151B (no)
MX (1) MXPA01013407A (no)
NO (1) NO321714B1 (no)
NZ (1) NZ517013A (no)
PL (1) PL194193B1 (no)
PT (1) PT1196383E (no)
SK (1) SK285611B6 (no)
UA (1) UA72768C2 (no)
WO (1) WO2001002360A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354806B1 (ko) * 2000-06-21 2002-10-05 한국유나이티드제약 주식회사 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
KR100452491B1 (ko) * 2001-03-29 2004-10-12 한미약품 주식회사 신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
ATE454890T1 (de) * 2001-07-06 2010-01-15 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
AR037565A1 (es) * 2001-11-21 2004-11-17 Synthon Bv Formas de sales de amlodipina y procedimientos para prepararlas.
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
JP2008013489A (ja) * 2006-07-06 2008-01-24 Ohara Yakuhin Kogyo Kk ベシル酸アムロジピン含有錠剤
EP1975167A1 (en) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetone solvate of phthaloyl amlodipine
CN101812014B (zh) * 2010-04-28 2011-08-24 王明 一种苯磺酸氨氯地平化合物及其制法
CN102993083A (zh) * 2012-12-21 2013-03-27 王学军 一种苯磺酸氨氯地平的制备方法
CN104262237A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 氨氯地平自由碱的合成方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
DE19738943B4 (de) 1997-09-05 2008-01-03 Siemens Ag Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls

Also Published As

Publication number Publication date
PL352493A1 (en) 2003-08-25
CZ300509B6 (cs) 2009-06-03
CN1141297C (zh) 2004-03-10
EE200100686A (et) 2003-04-15
EP1196383A1 (en) 2002-04-17
WO2001002360A1 (en) 2001-01-11
EA004208B1 (ru) 2004-02-26
BG65657B1 (bg) 2009-05-29
JP3764386B2 (ja) 2006-04-05
CA2376540C (en) 2007-03-13
NZ517013A (en) 2003-08-29
KR20020022760A (ko) 2002-03-27
NO321714B1 (no) 2006-06-26
SK22002A3 (en) 2002-05-09
EE05398B1 (et) 2011-04-15
DE69922417D1 (de) 2005-01-05
AU4923799A (en) 2001-01-22
SK285611B6 (sk) 2007-04-05
AU777565B2 (en) 2004-10-21
UA72768C2 (en) 2005-04-15
CN1352634A (zh) 2002-06-05
KR100585442B1 (ko) 2006-06-02
MXPA01013407A (es) 2003-09-04
DE69922417T2 (de) 2005-12-01
BG106164A (en) 2002-07-31
EP1196383B1 (en) 2004-12-01
HK1044151A1 (en) 2002-10-11
CZ20014690A3 (cs) 2002-04-17
PL194193B1 (pl) 2007-05-31
US6596874B1 (en) 2003-07-22
NO20020029D0 (no) 2002-01-04
ATE283841T1 (de) 2004-12-15
CA2376540A1 (en) 2001-01-11
ES2234272T3 (es) 2005-06-16
JP2003503477A (ja) 2003-01-28
EA200200125A1 (ru) 2002-06-27
HK1044151B (zh) 2004-09-10
PT1196383E (pt) 2005-03-31
DK1196383T3 (da) 2005-02-21

Similar Documents

Publication Publication Date Title
NO20020029D0 (no) Fremgangsmåte for fremstilling av amilodipinbenzensulfonat
NO941101L (no) Quinazolin-derivater
ES2195510T3 (es) Derivados de imidazopiridina y procedimiento para prepararlos.
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
NO20002589D0 (no) Bifenylamidinderivater
ES2151850A1 (es) Intermedio para la sintesis de amiodipino para su obtencion y utilizacion correspondiente.
NO20023126L (no) Fremgangsmåte for fremstilling av citalopram
NO20002490D0 (no) FremgangsmÕte for fremstilling av 1,4-dihydropyridiner og forbindelser anvendt ved denne fremgangsmÕten
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
FI980530A0 (fi) Foerfarande foer framstaellning av ett N-bis-(2-(1,2-dikarboxietoxi)-etyl)adminderivat, produkter som erhaolls genom foerfarandet och anvaendning ar daerav
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
NO20026198D0 (no) Cykliske ketoner, deres fremstilling og deres anvendelse ved syntese av aminosyrer
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
EP1319646A4 (en) PROCESS FOR THE PREPARATION OF 3,5-BISALKYLPHENOLENE
WO2001094315A3 (en) Process for the preparation of pesticidal compounds
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
UA33033A (uk) Спосіб одержання безилату амлодипіну
DK1242390T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
BG102547A (en) Method for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidin p-toluenesulphonate
TH52886A3 (th) กรรมวิธีที่ปรับปรุงดีขึ้นสำหรับการเตรียมอนุพันธ์ของนอร์เบนโซมอร์เฟนที่ใช้ประโยชน์ทางเภสัชวิทยา

Legal Events

Date Code Title Description
MK1K Patent expired